Cancer proteomics is a rapidly developing fi eld and promises to accelerate the discovery of new diagnostic, prognostic and therapy-related biomarkers. Increasingly, the mechanisms of action of cancer drugs are defi ned at the molecular level. Th e possibility of detecting hundreds and thousands of proteins at the same point of time is a tool to defi ne proteins associated with response or resistance to therapy. Th is strategy has been applied successfully in cell culture models and is implemented as translational research tool in early clinical trials of new anti-cancer agents. Th is review aims to summarize basic concepts and techniques of proteome analysis, its challenges and limitations, and discusses the opportunities for cancer therapy.